Venous Thrombosis and Thromboembolism: Advanced Performance Protocols and Interpretation and Updates on Medical and Interventional Disease Management, Part 1
Deep vein thrombosis (DVT) and pulmonary embolism (PE) are relatively common diseases and are amenable to therapy, but with a potentially fatal outcome if untreated. The diagnosis can be made in most patients with the use of noninvasive imaging tests, but limitations exist. The standard first choice of investigation in patients with suspected DVT is compression ultrasonography (CUS). Pre-sonography evaluation, including clinical assessment of patient history and physical, Well’s Score and D-dimer assay, is important in clinical screening, as well as medical and interventional disease management. This course will provide attendees with details of advanced diagnostic protocols and interpretation and updates on medical and interventional disease management.
Original Release Date: September 2020
Review Date: September 2021; February 2023
Course Expiration Date: September 2022; February 2024
Cardiologists, Physician Assistants, Sonographers, Respiratory Therapists (Personal Growth), Nurses and Nurse Practitioners.
- Recognize the prevalence of DVT and VTE in the United States.
- Identify acquired and inherited risk factors and Virchow triad.
- Define pre-sonography testing – Clinical examination, Wells Score and D-Dimer essay.
- Optimize the use of duplex ultrasonography in the management of COVID-19 and DVT/VTE.
- Explain why LE duplex ultrasonography may not be the best diagnostic modality in the diagnosis of PE and examine its limitations.
- Recognize the appropriate management for calf vein thrombosis.
- Define ilio-femoral and femoro-popliteal DVT and explain their medical disease management.
- Explain oral anticoagulation vs. systemic heparin.
Ian Del Conde, M.D., FACC
Director, Vascular Medicine
Associate Director, Cardiology
Miami Cardiac & Vascular Institute
Baptist Health South Florida
Ian Del Conde, M.D., faculty for this educational activity, has no relevant financial relationship with ineligible companies* to disclose and he will not include off-label or unapproved product usage in his presentation or discussion.
Elliott J. Elias, M.D., conference director for this educational activity, disclosed that he is a member of the speakers' bureau for Abbott Laboratories, and he will not include off-label or unapproved product usage in his presentation or discussion.
Brian J. Schiro, M.D., conference director for this educational activity, disclosed that he receives grant/research support from Medtronic and the he is a member of the speakers' bureau for Penumbra and Sirtex. Dr. Schiro has also disclosed that his participation will include discussion of off-label or unapproved usage.
Muhammad Hasan, MBBch, RPVI, planner for this educational activity, has no relevant financial relationship with ineligible companies* to disclose, and that his participation will not include discussion of off-label or unapproved product usage.
Non-faculty contributors and others involved in the planning, development, and editing/review of the content have no relevant financial relationships to disclose with ineligible companies*.
*Ineligible companies - Companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 General certificate of attendance
- 1.00 Nurse Practitioners
- 1.00 Florida Board of Nursing
- 1.00 Florida Board of Respiratory Therapy
This site is supported on the most recent stable releases of the following browsers:
This site is supported on the following mobile devices:
If you are experiencing technical difficulties or have received an error message, please send an email to CME@baptisthealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours.